Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCombined Modality TherapyTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousMelphalanCyclophosphamideOsteotomyGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationTreatment OutcomeBlood Component RemovalMultiple MyelomaLymphoma, Non-HodgkinStem CellsMyeloablative AgonistsGraft vs Host DiseaseBusulfanHematopoietic Stem CellsBone Marrow TransplantationGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionSalvage TherapyRecurrenceCarmustineCytophagocytosisIfosfamideAntineoplastic AgentsVincristineDisease-Free SurvivalAmyloidosisHematopoiesisCytarabineHodgkin DiseaseCord Blood Stem Cell TransplantationRetrospective StudiesNeoplasmsSurvival RateTransplantation ChimeraTime FactorsTissue DonorsSurvival AnalysisDoxorubicinWhole-Body IrradiationInfectionLymphoma, T-CellHistocompatibilityCarboplatinPlatelet CountPOEMS SyndromeFollow-Up StudiesImmunosuppressive AgentsHistocompatibility TestingPrednisoneLeukemia, Myeloid, AcuteProspective StudiesDexamethasoneTransplantation, IsogeneicRecombinant ProteinsVidarabineBlood Cell CountLeukemiaLymphomaBone Marrow PurgingBlood CellsEmbryonic Stem CellsFatal OutcomeCytomegalovirus InfectionsFeasibility StudiesGraft vs Leukemia EffectAdult Stem CellsPrognosisMesenchymal Stem Cell TransplantationMyelodysplastic SyndromesImmunophenotypingBreast NeoplasmsChemotherapy, AdjuvantAnemia, AplasticLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousT-LymphocytesLymphocyte DepletionBone MarrowHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocytes, MononuclearCell SeparationOpportunistic InfectionsPluripotent Stem CellsHistiocytosis, Non-Langerhans-Cell